在与瘤相关的免疫细胞中,P2纯能受体的表达和功能
Vahinipriya Manoharan1, Oluwafemi O Adegbayi1, Janielle P Maynard2,3
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Purinergic signalling
|October 10, 2024
概括
在癌症中,P2纯能受体被改变,影响瘤细胞和瘤微环境 (TME). 针对免疫细胞上的这些受体可能提供新的癌症免疫疗法策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在各种癌症亚型中,P2纯能受体表达失调,与较差的患者结果相关.
- 这些受体在瘤细胞的攻击性中起着至关重要的作用,对于瘤微环境 (TME) 内的癌症发病和进展至关重要.
研究的目的:
- 讨论瘤相关免疫细胞中P2纯能受体的表达和功能.
- 为研究新型免疫治疗策略的TME中的P2纯能受体提供理由.
主要方法:
- 文献综述和现有关于癌症P2纯敏受体表达的研究的综合.
- 在TME内的免疫细胞中P2纯能受体作用的分析.
主要成果:
- P2纯能受体在TME内的关键免疫细胞 (巨细胞,中性粒细胞,T细胞,树突细胞) 上表达.
- 这些受体会影响与瘤启动,促进和治疗反应相关的免疫细胞功能.
结论:
- P2纯能受体是TME内的免疫细胞活性的关键调节者.
- 对P2纯能受体作为治疗点的进一步研究有望为开发新型癌症免疫疗法提供希望.
更多相关视频
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


